Chimeric adenoviral (Ad5.F35) and listeria vector prime-boost immunization is safe and effective for cancer immunotherapy
John C. Flickinger(Thomas Jefferson University), Adam E. Snook(Thomas Jefferson University)
Cited by 16
Related Papers
CD5 deletion enhances the antitumor activity of adoptive T cell therapies
|Science Immunology|2024|45
CD8α Structural Domains Enhance GUCY2C CAR-T Cell Efficacy
|Cancer Biology & Therapy|2024|9